Biogland Ireland (r&d) Limited

Bioglan Laboratories Limited

Bioglan Ireland (r&d) Limited

Michael Goodman

Ake Lindahl

David J Howlett

James Ferguson

A device for providing pharmaceutical doses comprising a container, filled with a pharmaceutical composition including a pharmaceutically active agent in a solution of liquified 1,1,1,2-tetrafluoroethane (HFC-134 ), or 1,1,1,2,3,3,3 heptafluoropropane (HFC-227) and a carrier. The carrier can be a pharmaceutically acceptable alcohol, polyol, (poly)alkoxy derivative, fatty acid alkyl ester, polyalkylene glycol, or dimethyl sulphoxide. The device includes a valve arranged for delivering aerosol doses of said pharmaceutical composition to the exterior of the container, and at least a portion of the device is formed from a polyester.

Pharmaceutical compositions and devices for their administration

A viscous hydrogel composition, for use in a topical treatment of a skin condition involving dry or inflammed skin, comprising an antimicrobially active nitroimidazole drug, a water miscible alkylene glycol, a bydroxyalkyl cellulose gelling agent and water, buffered to have a physiologically acceptable pH and a method of making the same.

Nitroimidazole gel composition

A device for providing pharmaceutical doses comprising a container, filed with a pharmaceutical composition including glyceryl trinitrate and 1,1,1,2-tetrafluoroethane, or 1,1,1,2,3,3,3-heptafluoropropane, as a propellant, and a valve arranged for delivering aerosol doses of said pharmaceutical composition to the exterior of the container, wherein at least a portion of the device is formed from a polyester.

Growing community of inventors

Ampthill, United Kingdom

Michael Goodman